Traduction de «patients undergoing non cardiac surgery » (Français → Néerlandais) :

50. von Kemp K. Preoperative cardiac management of patients undergoing non cardiac surgery.
48. von Kemp K. Preoperative cardiac management of patients undergoing non cardiac surgery.

Mondillo et al 44 2002 RCT yes 188 Among subjects undergoing major vascular surgery, severity and extent of ischemia during DSE and presence of > 3 reversible perfusion defects are strong predictors of cardiac events particularly in moderate risk patients
Mondillo et al 42 2002 RCT yes 188 Among subjects undergoing major vascular surgery, severity and extent of ischemia during DSE and presence of > 3 reversible perfusion defects are strong predictors of cardiac events particularly in moderate risk patients

34. Sicari R. Perioperative risk stratification in non cardiac surgery: role of pharmacological stress echocardiography.
34. Barasch E, Wilansky S. Dobutamine stress echocardiography in clinical practice with a review of the recent literature.

Source Statement ACA Not included ACP Not included ASA Selected patients : Agreement : 90 % of consultants, 92 % ASA Members To consider : smoking, recent infection, COPD, and cardiac disease ICSI Selected patients with signs or symptoms suggesting new or unstable cardiopulmonary disease INAHTA Chest X-ray abnormality correspond more closely with ASA status than with age (McCleane) i The results of between 0% and 2.1% of chest X-rays leads to a change in management There is no published evidence that routine preoperative chest X-rays decrease perioperative risks ii . NICE Minor surgery: ASA I : not indicated ASA II : consider > 40 y if respiratory or CV disease ASA III : consider if respiratory or CV disease Intermediate surgery: ASA I : not indicated ASA II : consider if respiratory or CV disease (renal > 60y) ASA III : consider if respiratory, CV or renal disease Major surgery: ASA I : consider > 60 ASA II : consider if respiratory, CV or renal disease ASA III : consider if respiratory, CV or renal disease
Source Statement ACA Not included ACP Not included ASA Selected patients : Agreement : 90 % of consultants, 92 % ASA Members To consider : smoking, recent infection, COPD, and cardiac disease ICSI Selected patients with signs or symptoms suggesting new or unstable cardiopulmonary disease INAHTA Chest X-ray abnormality correspond more closely with ASA status than with age (McCleane) i The results of between 0% and 2.1% of chest X-rays leads to a change in management There is no published evidence that routine preoperative chest X-rays decrease

48 higher specificity than nuclear cardiology techniques Van Damme H et al - 1997 Prospective clinical yes 156 It is concluded that complementary non invasive Cardiovascular Surgery 49 study cardiac stress testing by dobutamine is indicated only
46 higher specificity than nuclear cardiology techniques Van Damme H et al - 1997 Prospective clinical yes 156 It is concluded that complementary non invasive Cardiovascular Surgery 47 study cardiac stress testing by dobutamine is indicated only

29. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.
30. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.

Prévention de maladies cardiovasculaires L'effet de l'atorvastatine sur les événements coronaires mortels et non mortels a été évalué dans une étude randomisée, en double aveugle contrôlée versus placebo, « The Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm » (ASCOT-LLA), chez des patients hypertendus âgés de 40 à 79 ans, sans antécédent d'infarctus du myocarde ni d'angor traité, et présentaient des taux de CT ≤ 6,5 mmol/l (251 mg/dl).
Preventie van hart- en vaataandoeningen In een gerandomiseerde, dubbelblinde, placebo-gecontroleerde studie, de Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT-LLA) werd het effect bepaald van atorvastatine op fatale en niet-fatale coronaire hartziekte. De patiënten hadden hypertensie, waren 40-79 jaar oud, hadden niet eerder een myocardinfarct gehad, waren niet eerder voor angina behandeld en hadden een totale cholesterol-spiegel ≤6,5 mmol/l (251 mg/dl).

L'effet de l'atorvastatine sur les événements coronaires mortels et non mortels a été évalué dans une étude randomisée, en double aveugle contrôlée versus placebo, « The Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm » (ASCOT-LLA), chez des patients hypertendus âgés de 40 à 79 ans, sans antécédent d'infarctus du myocarde ni d'angor traité, et présentaient des taux de CT ≤ 6,5 mmol/l (251 mg/dl).
In een gerandomiseerde, dubbelblinde, placebo-gecontroleerde studie, de Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT-LLA) werd het effect bepaald van atorvastatine op fatale en niet-fatale coronaire hartziekte. De patiënten hadden hypertensie, waren 40-79 jaar oud, hadden niet eerder een myocardinfarct gehad, waren niet eerder voor angina behandeld en hadden een totale cholesterol-spiegel ≤6,5 mmol/l (251 mg/dl).

DCD Donor after Cardiac Death = Non Heart Beating Donor= NHBD Un prélèvement NHBD peut être envisagé dans plusieurs cas de figure, chez des patients en état de mort cardiaque ou chez qui une mort cardiaque va survenir dans un délai court.
DCD Donor after Cardiac Death = Non Heart Beating Donor= NHBD NHBD-donatie kan in verschillende gevallen worden overwogen bij patiënten die ofwel hartdood zijn of bij wie in zeer korte tijd hartstilstand zal optreden.

47 2001 literature review ------- ------------- For intermediate risk patients, no prospective RCT demonstrates the efficacy of non invasive stress testing or subsequent revascularization for preventing perioperative cardiac events.
45 2001 literature review ------- ------------- For intermediate risk patients, no prospective RCT demonstrates the efficacy of non invasive stress testing or subsequent revascularization for preventing perioperative cardiac events.